-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Larimar Therapeutics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from 2020 to 2024.
- Larimar Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending December 31, 2024 was 61.3M shares, a 39.5% increase year-over-year.
- Larimar Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2024 was 61.3M shares, a 39.5% increase from 2023.
- Larimar Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 43.9M shares, a 70.4% increase from 2022.
- Larimar Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 25.8M shares, a 50.1% increase from 2021.
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Growth (%)